Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Haemonetics (NYSE:HAE) announced that President and CEO Chris Simon will join a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.

Rhea-AI Summary

Haemonetics (NYSE:HAE) announced that President and CEO Chris Simon will join a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.

A live webcast and 90-day replay will be available via Haemonetics' Investor Relations website.

Argus Jun 3 session

-0.74% close to close Open Argus

Details

News Market Reaction – HAE

In the Jun 3 session, HAE declined 0.74%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights continued investor outreach, with the CEO scheduled for a fireside chat...

Analysis

This announcement highlights continued investor outreach, with the CEO scheduled for a fireside chat at a major healthcare conference on June 8, 2026 at 4:00 p.m. ET. It follows recent earnings, FDA developments, and other conference appearances. The live webcast and 90-day replay provide broad access for stakeholders to hear management’s messaging. Investors may focus on how commentary aligns with prior guidance, product strategy, and the company’s recent regulatory and clinical milestones.

Key Figures

Conference edition: 47th Annual Event date and time: June 8, 2026 at 4:00 p.m. ET Webcast replay delay: 12 hours +1 more

Conference edition

47th Annual

Goldman Sachs Global Healthcare Conference

Event date and time

June 8, 2026 at 4:00 p.m. ET

Scheduled fireside chat with investors

Webcast replay delay

12 hours

Time after event when replay becomes accessible

Replay availability

90 days

Duration webcast replay will be hosted

Historical Context

5 past events · Latest: May 07

5 events

1. May 07

   Earnings results posted

   24h Move

   +3.2%

   Fourth quarter fiscal 2026 results posted with webcast and replay details.

2. May 05

   Conference appearance

   24h Move

   +0.5%

   CEO fireside chat at Bank of America 2026 Healthcare Conference announced.

3. Apr 24

   Clinical study data

   24h Move

   +0.5%

   574-patient study showed strong safety and efficacy for VASCADE MVP XL.

4. Apr 01

   Earnings date set

   24h Move

   +1.1%

   Announcement of timing for Q4 and fiscal 2026 results and conference call.

5. Mar 30

   FDA approval

   24h Move

   +2.6%

   FDA approval for expanded labeling of VASCADE MVP XL for larger sheaths.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:
https://event.webcasts.com/starthere.jsp?ei=1766065&tp_key=0b16b4b62d&tp_special=8
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Sr. Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference-302788972.html

SOURCE Haemonetics Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Haemonetics (NYSE:HAE) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Haemonetics will participate in a fireside chat on Monday, June 8, 2026 at 4:00 p.m. ET. According to Haemonetics, President and CEO Chris Simon will represent the company in this investor-focused session.

Who will represent Haemonetics (HAE) at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026?

Haemonetics will be represented by Chris Simon, President and CEO, in a fireside chat with investors. According to Haemonetics, this session is part of the Goldman Sachs 47th Annual Global Healthcare Conference.

How can investors access the Haemonetics (HAE) webcast from the Goldman Sachs Global Healthcare Conference 2026?

Investors can access a live webcast of the Haemonetics fireside chat via the company’s Investor Relations website. According to Haemonetics, a direct webcast link is also provided for public access.

Will a replay be available for Haemonetics’ (HAE) Goldman Sachs 2026 healthcare conference fireside chat?

Yes, a replay will be available 12 hours after the event. According to Haemonetics, the recorded webcast replay will remain accessible for 90 days on the company’s Investor Relations website.

What type of session will Haemonetics (HAE) hold at the Goldman Sachs 47th Annual Global Healthcare Conference?

Haemonetics will participate in a fireside chat with investors rather than a formal presentation. According to Haemonetics, President and CEO Chris Simon will join this discussion on June 8, 2026 at 4:00 p.m. ET.